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Introduction: Tubulointerstitial nephritis and uveitis syndrome is a disorder characterized by a combination of acute
tubulointerstitial nephritis and uveitis. Immunoglobulin A nephropathy is defined by the presence of immunoglobulin
A deposits in glomerular mesangial areas. In this report, we describe a rare case of tubulointerstitial nephritis and
uveitis syndrome complicated by immunoglobulin A nephropathy and Graves’ disease, which was successfully
treated with corticosteroids. To the best of our knowledge, this is the first time such a case has been documented
since tubulointerstitial nephritis and uveitis syndrome was first described.
Case presentation: A 64-year-old Japanese woman presented with tubulointerstitial nephritis and uveitis syndrome
accompanied by immunoglobulin A nephropathy and Graves’ disease. She had renal dysfunction, proteinuria, and
hematuria. Two weeks after her admission, she developed anterior chamber uveitis. She received corticosteroids,
resulting in significant clinical improvement.
Conclusion: Tubulointerstitial nephritis and uveitis syndrome is a relatively uncommon cause of tubulointerstitial
nephritis. Clinicians should recognize that tubulointerstitial nephritis and uveitis syndrome with immunoglobulin A
nephropathy can occur in the presence of Graves’ disease. Additionally, this report may provide important clues in
terms of the management of a concomitant case of these diseases.
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Tubulointerstitial nephritis and uveitis (TINU) syndrome
is defined by acute tubulointerstitial nephritis associated
with uveitis that occurs either simultaneously, prior to, or
following the onset of renal dysfunction [1]. By contrast,
immunoglobulin A (IgA) nephropathy is the most preva-
lent primary chronic glomerulonephritis in Japan as well
as worldwide [2], and is characterized by IgA and C3 de-
position in glomerular mesangial regions. According to
the Japan Renal Biopsy Registry, there were 239 cases of
IgA nephropathy in 2007 and 424 cases in 2008 [3]. The
clinical course of IgA nephropathy is variable, but one
quarter of patients will have end-stage renal diseases* Correspondence: yoshinosukeshimamura@gmail.com
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article, unless otherwise stated.after 20 years, and a further 20% will have progressive
impairment of renal function [4]. In both TINU and IgA
nephropathy, the pathogenesis is thought to be an auto-
immune process that might involve humoral and cellular
autoimmunity [5,6]. The standard treatment of IgA ne-
phropathy is corticosteroids, resulting in preserving renal
function over the long term [7]. The standard therapy of
TINU syndrome is still not clear.
We describe the case of a patient with TINU syn-
drome complicated by IgA nephropathy and Graves’ dis-
ease, which was treated successfully with corticosteroids,
leading to a decline in proteinuria and normalized renal
function.Case presentation
A 64-year-old Japanese woman presented with a sore
throat and hematuria of three days duration. She reportedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 2 Renal biopsy (immunofluorescence, ×400). Diffuse
mesangial deposit of immunoglobulin A.
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showed no other abnormalities. Besides Graves’ disease,
she had hypertension and was taking propylthiouracil,
amlodipine, and candesartan; she had no known aller-
gies. She had never smoked or used recreational drugs
and only occasionally drank alcohol. She had no family
history of kidney disease. A physical examination re-
vealed the following vital signs: temperature, 37.1°C;
heart rate, 94 beats per minute; blood pressure, 115/
80mmHg; respiratory rate, 12 breaths per minute; and
O2 saturation, 98% on room air. A head and neck exam-
ination showed her oropharynx to be erythematous with
swollen tonsils and pus. She had multiple, tender, mobile,
5mm bilateral cervical lymphadenopathy. The patient
denied short of breath, sputum production, difficulty
swallowing. Her thyroid, chest, and abdominal examina-
tions showed no abnormalities, along with the rest of her
examination.
One year prior to her presentation, our patient’s renal
function and urine analysis were as follows: blood urea
nitrogen (BUN), 12.1mg/dL; creatinine (Cr), 1.1mg/dL; and
estimated glomerular filtration rate (eGFR), 59mL/min
per 1.73m2 according to the Modification of Diet in
Renal Disease equation. Her urinary sediment at that
time revealed 10 to 19 erythrocytes and one to four leuko-
cytes per high-power field, and no casts were noted. On
her current admission, significant laboratory findings in-
cluded a white blood cell count of 23,310 cells/μL, BUN
of 15.4mg/dL, Cr of 1.4mg/dL, and eGFR of 51mL/min
per 1.73m2 according to the Modification of Diet in Renal
Disease equation. Findings from a thyroid function panel
were within normal limits. Her erythrocyte sedimentation
rate (ESR) was 62mm/h. A rapid strep test on a throat cul-
ture was positive for Streptococcus pyogenes, for which sheFigure 1 Renal biopsy (periodic acid silver methenamine-Masson
trichrome, ×40). Mild proliferation of mesangial cells (arrow head),
with three or more cells per mesangial area, and increase of mesangial
matrix (arrow).was given ceftriaxone. Urine analysis on a spot urine ana-
lysis revealed a protein/creatinine ratio of 2.0g/g.Cr. Her
urinary protein was 2.6g/day; her urinary sediment re-
vealed 50 to 99 erythrocytes and one to four leukocytes
per high-power field, and no casts were noted.
Two weeks later, our patient developed bilateral ciliary
injection and photophobia; slit lamp examination re-
vealed anterior chamber uveitis. Laboratory findings were
as follows: BUN, 26mg/dL; Cr, 2mg/dL; anti-nuclear anti-
body titer, 1:320; and IgA, 497mg/dL (normal range: 90
to 400mg/dL). A urine analysis at this time revealed
protein of 3.2g/day and β2-microglobulin of 1347/μL
(normal 0-250/μL). Histological examination of a kidney
biopsy specimen showed one cellular crescent, increased
mesangial cell proliferation (Figure 1), and deposition ofFigure 3 Renal biopsy (hematoxylin and eosin, ×40). In the renal
tubular interstitium, marked immune cell infiltration, composed of
mainly lymphocytes and edema, was observed (arrow). In addition,
tubular atrophy was observed (arrow head).
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phropathy. The interstitium, however, showed tubular
atrophy, edematous changes, and infiltration of granular
leukocytes (Figure 3). Along with the uveitis, her ele-
vated ESR, the excretion of urinary β2-microglobulin,
and the histology of the kidney specimen were highly
suggestive of TINU syndrome. Given her diagnosis of
TINU syndrome [1] complicated by IgA nephropathy,
she was given methylprednisolone for three days with
subsequent oral prednisolone for two months, with clinical
improvement.
Discussion
In this case, we made two important clinical observations.
First, this is the first reported case of IgA nephropathy
complicated by TINU syndrome with underlying Graves’
syndrome. IgA nephropathy is often associated with other
conditions, particularly with hepatic diseases and auto-
immune diseases [8]. Ku et al. reported the case of a pa-
tient with Graves’ disease complicated by IgA nephropathy
but not TINU syndrome [9]. Several researchers have
reported the concurrence of TINU syndrome and IgA ne-
phropathy with [10,11] or without underlying autoimmune
diseases [12-14]. Therefore, we need to hold a high clinical
suspicion for other autoimmune-mediated diseases in pa-
tients with IgA nephropathy. However, to the best of our
knowledge, there are no previously reported cases of IgA
nephropathy complicated by TINU syndrome with under-
lying Graves’ disease.
Our second observation is that corticosteroid therapy
significantly improved both our patient’s IgA nephropa-
thy and TINU syndrome. It appears beneficial in moder-
ate or severe cases of IgA nephropathy [15] whereas it is
still not clear that steroid therapy is required for the re-
covery of tubulointerstitial nephritis. In terms of IgA ne-
phropathy, Kidney Disease Improving Global Outcomes
guidelines recommend six months of glucocorticoids
when there is persistent proteinuria is over 1g/day, and
GFR greater than 50mL/min per 1.73m2 [15]. In regards
to TINU, whether corticosteroids are beneficial for neph-
ritis is still unknown. Some patients receive oral steroids
to treat the renal dysfunction and the response is favorable
[16,17], but other patients were reported to recover spon-
taneously without any drugs, including steroids [18,19]. In
this case, we successfully treated both our patient’s renal
function and uveitis.
This case report has limitations that must be noted.
First, tubulointerstitial lesions can be associated with ag-
gravation of IgA nephropathy. Second, the role of cortico-
steroids in the treatment of TINU syndrome remains to be
defined. In the absence of prospective randomized double-
blind trials, we are compelled to use evidence from small,
uncontrolled series. However, we used corticosteroids in
our patient because her renal function deteriorated.We may speculate on the pathogenesis of this case as
follows. Because the contribution of Streptococcus infec-
tion to the pathogenesis of IgA nephropathy has been
reported [20], we can infer first of all that a Strepto-
coccus infection triggered her humoral immune re-
sponses, causing IgA nephropathy. Subsequently, these
reactions may have activated abnormal immune responses,
with cellular and humoral interactions resulting in TINU
syndrome.
Conclusion
We report on a rare case of TINU complicated by IgA
nephropathy and Graves’ disease, successfully treated
with corticosteroids. Clinicians should be aware that
TINU syndrome may complicate other autoimmune dis-
eases (for example (11,12]). In addition, a multicenter
prospective trial investigating the role of early steroid
therapy in TINU is necessary.
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